• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过Toll样受体进行病原体识别。

Pathogen recognition with Toll-like receptors.

作者信息

Kawai Taro, Akira Shizuo

机构信息

Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

Curr Opin Immunol. 2005 Aug;17(4):338-44. doi: 10.1016/j.coi.2005.02.007.

DOI:10.1016/j.coi.2005.02.007
PMID:15950447
Abstract

The innate immune system is an evolutionarily conserved system of defense against microbial infections. The family of Toll-like receptors is a major class of receptors that sense molecular patterns associated with a broad range of pathogens including bacteria, viruses, fungi and protozoa. Following pathogen recognition, Toll-like receptors initiate intracellular signal transduction that results in the expression of genes involved in inflammation, antiviral responses and maturation of dendritic cells. Individual Toll-like receptors activate common and unique transcription factors through different signaling pathways to drive specific biological responses against microorganisms.

摘要

先天免疫系统是一种针对微生物感染的进化上保守的防御系统。Toll样受体家族是一类主要的受体,可识别与包括细菌、病毒、真菌和原生动物在内的多种病原体相关的分子模式。在病原体识别后,Toll样受体启动细胞内信号转导,导致参与炎症、抗病毒反应和树突状细胞成熟的基因表达。单个Toll样受体通过不同的信号通路激活共同和独特的转录因子,以驱动针对微生物的特定生物学反应。

相似文献

1
Pathogen recognition with Toll-like receptors.通过Toll样受体进行病原体识别。
Curr Opin Immunol. 2005 Aug;17(4):338-44. doi: 10.1016/j.coi.2005.02.007.
2
Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.Toll样受体与宿主对微生物病原体的防御:赋予先天免疫系统特异性。
J Leukoc Biol. 2004 May;75(5):749-55. doi: 10.1189/jlb.1103543. Epub 2004 Jan 14.
3
Pathogen recognition and innate immunity.病原体识别与固有免疫
Cell. 2006 Feb 24;124(4):783-801. doi: 10.1016/j.cell.2006.02.015.
4
Toll-like receptors in innate immunity.天然免疫中的Toll样受体
Int Immunol. 2005 Jan;17(1):1-14. doi: 10.1093/intimm/dxh186.
5
Signal integration following Toll-like receptor triggering.Toll样受体触发后的信号整合
Crit Rev Immunol. 2002;22(3):217-50.
6
Toll-like receptors.Toll样受体
Crit Care Med. 2002 Jan;30(1 Suppl):S1-11.
7
Innate immunity and toll-like receptors: clinical implications of basic science research.固有免疫与Toll样受体:基础科学研究的临床意义
J Pediatr. 2004 Apr;144(4):421-9. doi: 10.1016/j.jpeds.2004.01.057.
8
Pathogen recognition by the innate immune system.先天免疫系统识别病原体。
Int Rev Immunol. 2011 Feb;30(1):16-34. doi: 10.3109/08830185.2010.529976.
9
Toll-like receptor signaling pathways.Toll样受体信号通路。
Science. 2003 Jun 6;300(5625):1524-5. doi: 10.1126/science.1085536.
10
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.

引用本文的文献

1
STAT Signature Dish: Serving Immunity with a Side of Dietary Control.STAT特色菜品:提供免疫力并辅以饮食控制。
Biomolecules. 2025 Mar 26;15(4):487. doi: 10.3390/biom15040487.
2
De novo design of protein minibinder agonists of TLR3.Toll样受体3的蛋白质微型结合激动剂的从头设计
Nat Commun. 2025 Jan 31;16(1):1234. doi: 10.1038/s41467-025-56369-w.
3
Immunoinformatic based designing of highly immunogenic multi-epitope subunit vaccines to stimulate an adaptive immune response against Junin virus.基于免疫信息学设计高免疫原性多表位亚单位疫苗以刺激针对胡宁病毒的适应性免疫反应。
Mol Divers. 2024 Dec 18. doi: 10.1007/s11030-024-11082-6.
4
The rs6967330 minor allele in CDHR3 is a significant risk factor for severe acute exacerbations in chronic rhinosinusitis.CDHR3基因中的rs6967330次要等位基因是慢性鼻-鼻窦炎严重急性加重的重要危险因素。
J Allergy Clin Immunol. 2025 Feb;155(2):583-593. doi: 10.1016/j.jaci.2024.09.025. Epub 2024 Oct 9.
5
A first-in-kind MAPK13 inhibitor that can correct stem cell reprogramming and post-injury disease.一种能够纠正干细胞重编程和损伤后疾病的首创丝裂原活化蛋白激酶13(MAPK13)抑制剂。
bioRxiv. 2024 Aug 22:2024.08.21.608990. doi: 10.1101/2024.08.21.608990.
6
MAPK13 controls structural remodeling and disease after epithelial injury.丝裂原活化蛋白激酶13(MAPK13)控制上皮损伤后的结构重塑和疾病。
bioRxiv. 2024 Aug 10:2024.05.31.596863. doi: 10.1101/2024.05.31.596863.
7
Revolution in sepsis: a symptoms-based to a systems-based approach?脓毒症的革命:从基于症状的方法到基于系统的方法?
J Biomed Sci. 2024 May 30;31(1):57. doi: 10.1186/s12929-024-01043-4.
8
De novo design of protein minibinder agonists of TLR3.Toll样受体3(TLR3)蛋白微型结合激动剂的从头设计
bioRxiv. 2024 Apr 18:2024.04.17.589973. doi: 10.1101/2024.04.17.589973.
9
Epidemiology, pathogenesis, immune evasion mechanism and vaccine development of porcine Deltacoronavirus.猪德尔塔冠状病毒的流行病学、发病机制、免疫逃逸机制及疫苗研发。
Funct Integr Genomics. 2024 Apr 24;24(3):79. doi: 10.1007/s10142-024-01346-7.
10
Mitogen-activated protein kinase-guided drug discovery for post-viral and related types of lung disease.丝裂原活化蛋白激酶指导的药物研发用于病毒性和相关类型的肺部疾病。
Eur Respir Rev. 2024 Feb 28;33(171). doi: 10.1183/16000617.0220-2023. Print 2024 Jan 31.